Financial Overview

Financials

Sequent Scientific Limited is India’s leading animal health company.

Quarterly Financial - Results

The SeQuent financial reports

Select Year and Quater

Earning Call Audio Recording

Investor Presentation Q4 FY 25

Financial Results FY 2024-25

Investor Conference intimation 21st May 2025

Call transcript

Investor Call Recording

Newspaper Publication for Q3 Financial results

Financials

Investor Prsenation

Call transcript

Newspaper

Financial

Investor presentation

Investor call recording

Call Transcript

Earnings Call Audio Recording

Earning Presentation

Signed Financials

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Earnings Call Audio Recording

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Signed Financials

Earning Presentation

Call Transcript

Investors Presentation Nov 2019

Signed Financials

Earning Presentation

Call Transcript

Share holding pattern

The SeQuent financial reports

Select Year and Quater

Quarter ended 4

Quarter ended 3

Quarter ended 2

Quarter ended 1

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Quarter ended 1

Quarter ended 2

Quarter ended 3

Quarter ended 4

Select Year

Press Release and Investor Presentation

Sequent Scientific Limited Receives Prequalification Approval from World Health Organization (WHO) for Albendazole API

SeQuent Scientific and Viyash Lifesciences Announce Strategic Merger to Create a Global Animal Health Leader with End-to-End Integrated Capabilities

SeQuent Scientific Appoints Pharmaceutical Industry Leader Rajaram Narayanan as Managing Director and CEO

Acquisition of Nourrie

SeQuent announced EUGMP approval for its tablets dosage form in Turkey

SeQuent Scientific Ltd Press Release Q4 FY21

SeQuent received CEP approval for Diclazuril API

Corporate update – December 22, 2020

Investors/analysts Conference Call – Corporate Update – December 22, 2020

SeQuent announced launch of Citramox® LA in EU

Launch of inhouse developed Halofusol® in EU

SeQuent Scientific Ltd PR Q2 FY21

SeQuent Announces Reconstitution of Board

SeQuent Scientific provides Covid-19 and Business Update

Sequent Scientific announces WHO-Geneva approval for its Vizag facility

Sequent Scientific announces addition of new state-of-art Animal Health R&D Centre at Mumbai

SeQuent Scientific receives EIR from US FDA for its Analytical Laboratory at Bengaluru

Earnings Transcript May 14, 2019

SeQuent Scientific Announces Q4 and Annual FY19 Financial

Change in Credit Rating

Earning Transcripts February 1, 2019

Sequent financials press release SeQuent Scientific Announces Q3 FY19 Financial Results

SeQuent Scientific Ltd. receives EIR from USDFA for its Analytical Lab at Mangalore

Earning Transcripts November 2, 2018

SeQuent Scientific Announces Q2 FY19 Financial Results

Earning Transcripts August 10 2018

SeQuent Scientific Announces Q1 FY19 Financial Results

Sequent Scientific Earnings Transcript Q4 FY 18 Financial Results

SeQuent Scientific Announces Q4 FY18 Financial Results alongwith Investors Presentation

SeQuent Scientific Announces Q3 FY18 Financial Results

Sequent Scientific Announces Q2 FY 18 Financial Results

Sequent Scientific Announces Q1 FY 18 Financial Results

SeQuent Scientific announces FY17 Financial Results

Establishment Inspection Report – Visakhapatnam (Vizag) Plant

SeQuent Scientific announces Q3FY17 Financial Results

SeQuent Scientific to become a pur-play Animal Health Company

SeQuent Scientific announces Q2FY17 Financial Results

SeQuent Scientific announces Q1FY17 Financial Results

Alivira completes the acquisition of 70% stake in Interchange, Brazil

Alivira to acquire majority stake in Karizoo Group Spain

SeQuent Scientific announces FY16 Financial Results

Alivira to acquire controlling interest in Interchange Brazil

SeQuent Scientific Mahad Facility Receives Environment Clearance from SEIAA

SeQuent Scientific announces Q3FY16 Financial Results

Sequent Scientific to acquire controlling stake in Indo Phyto Chemicals Forays into steroids and hormones for Female Healthcare

Alivira forays into European Veterinary Market

Alivira to acquire Topkim, Turkey Will make Alivira the largest Animal Health Company of Turkey

SeQuent receives Establishment Inspection Report from US FDA for its API Drug Manufacturing Facility at Mangalore

SeQuent Scientific announces Q2FY16 Financial Results

SeQuent Scientific completes acquisition of Animal Health business of Lyka Exports

SeQuent Scientific to acquire Animal Health business of Lyka Exports

SeQuent Scientific announces Q1FY16 Financial Results

SeQuent Scientific announces Q1FY16 Financial Results

SeQuent Scientific completes fund raise of INR 4,000 mn through Qualified Institutional Placement

SeQuent Scientific announces Q4 – FY 2014-15 Results

SeQuent Scientific announces Q3 – FY 2014-15 Results

SeQuent Scientific announces Q2 – FY 2014-15 Results

SeQuent Scientific announces Q1 – FY 2014-15 Results

Sequent Scientific announces licensing agreement with Gilead Sciences, Inc for new Hepatitis C drug

Alivira Animal Health to acquire majority stake in Provet Veterinary Products AS of Turkey

SeQuent Scientific Limited announces completion of Sale of Specialty Chemicals division to Songwon Industrial Group

SeQuent Scientific announces FY 2013-14 Results

SeQuent Scientific to acquire the business of Arvee Synthesis

Songwon Industrial Group to acquire Specialty Chemicals Division of SeQuent Scientific Limited

SeQuent Scientific to acquire the business of Arvee Synthesis Acquisition to provide impetus to Human API business

Songwon Industrial Group to acquire Specialty Chemicals Division of SeQuent Scientific Limited

Sequent Scientific Ltd & Shasun Pharmaceuticals Ltd Announce Joint Venture To Create Leading Animal Health Company

Sequent Scientific Receives Us Fda Approval For Its Api Drug Manufacturing Facility At Mangalore

36th AGM Presentation

35th AGM Presentation

Investors Presentation Nov 2019

34th AGM Presentation

Investors Presentation May 2019

Investors Presentation February 2019

Investors Presentation November 2018

Investors Presentation September 2018

Investor Presentation AGM September 27, 2018

Investors Presentation August 2018

Investors Presentation June 2018

Investors Presentation March 2018

Investors Presentation January 2018

Investors Presentation November 2017

Investors Presentation September 26, 2017

Investors Presentation September 22, 2016

AGM Presentation 2015-16

General Meeting Presentation

Corporate Presentation

Investors Presentation

Select Year

MGT-7 2023-24

Business Responsibility and Sustainability FY 23-24

Annual Report 2023-24

Business Responsibility and Sustainability FY 22-23

Postal ballot notice Sept 20, 2023

MGT 7 2022-23

Annual Report 2022-23

Postal Ballot Notice-November 10, 2022

Certificate under 163(2)

Business Responsibility Report FY 2021-22

AGM Notice 2021-22

Annual Report 2021-22

Annual Return 2021-22

Report FY 2021-22

Postal Ballot Notice January 14, 2022

2020-21

MGT-7;2020-21

Postal Ballot Notice February 08, 2021

Postal Ballot Notice August 12, 2020

Postal Ballot Notice December 14, 2020

2019-20

MGT-9; 2019-20

MGT-9; 2018-19

MGT-7; 2018-19

2018-19

2017-18

2016-17

Green Initiative Form

2015-16

2014-15

2013-14

2012-13

2011-12

2010-11

2009-10